• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将经皮冠状动脉介入治疗与 Taxus 和心脏手术(SYNTAX)评分的协同作用整合到实践中:使用、陷阱和新方向。

Integrating the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score into practice: use, pitfalls, and new directions.

机构信息

Ferrarotto Hospital, University of Catania, Italy.

出版信息

Am Heart J. 2011 Mar;161(3):462-70. doi: 10.1016/j.ahj.2010.11.018. Epub 2011 Jan 31.

DOI:10.1016/j.ahj.2010.11.018
PMID:21392599
Abstract

Risk stratification is key in optimizing care of patients undergoing percutaneous coronary intervention (PCI). Score algorithms, in particular, are useful prognostic tools to select the most appropriate strategy of treatment and help patients and their families to get a better understanding of issues relevant to treatment strategies and subsequent risks. Most scores tested in the setting of PCI focus on clinical variables. The SYNTAX score is a semiquantitative angiographic score developed to prospectively characterize the disease complexity of the coronary vasculature. This scoring system has recently been assessed in numerous cohorts of patients undergoing coronary revascularization by PCI or bypass surgery. When using the SYNTAX score, however, physicians are still challenged with a labor-intensive calculation and conflicting results from validation studies. Understanding how the SYNTAX score works, for which patients it works best, and whether it predicts accurately enough for its purpose is of paramount importance to get the maximum benefit from its application. The present article provides an overview of the background and the currently available evidences on the use of the SYNTAX score in patients undergoing coronary revascularization along with its limitations.

摘要

风险分层是优化经皮冠状动脉介入治疗(PCI)患者治疗的关键。评分算法,特别是预测预后的有用工具,可用于选择最合适的治疗策略,并帮助患者及其家属更好地了解与治疗策略和后续风险相关的问题。大多数在 PCI 环境中测试的评分都集中在临床变量上。SYNTAX 评分是一种半定量的血管造影评分,旨在前瞻性地描述冠状动脉血管的疾病复杂性。该评分系统最近已在接受 PCI 或旁路手术冠状动脉血运重建的众多患者队列中进行了评估。然而,在使用 SYNTAX 评分时,医生仍然面临着繁琐的计算和验证研究结果不一致的挑战。了解 SYNTAX 评分的工作原理、对哪些患者最有效以及其预测结果是否足够准确,对于从其应用中获得最大收益至关重要。本文概述了 SYNTAX 评分在接受冠状动脉血运重建的患者中的应用背景和现有证据,以及其局限性。

相似文献

1
Integrating the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score into practice: use, pitfalls, and new directions.将经皮冠状动脉介入治疗与 Taxus 和心脏手术(SYNTAX)评分的协同作用整合到实践中:使用、陷阱和新方向。
Am Heart J. 2011 Mar;161(3):462-70. doi: 10.1016/j.ahj.2010.11.018. Epub 2011 Jan 31.
2
Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.在接受经皮或外科左主干血运重建的患者中,全球风险分类和临床 SYNTAX(经皮冠状动脉介入治疗与紫杉醇和心脏手术之间的协同作用)评分。
JACC Cardiovasc Interv. 2011 Mar;4(3):287-97. doi: 10.1016/j.jcin.2010.10.013.
3
2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.超越SYNTAX(TAXUS药物洗脱支架经皮冠状动脉介入治疗与心脏手术协同作用)研究的奥地利多支血管TAXUS支架(AUTAX)注册研究的2年结果。
JACC Cardiovasc Interv. 2009 Aug;2(8):718-27. doi: 10.1016/j.jcin.2009.05.019.
4
Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization.SYNTAX(紫杉醇药物球囊与心脏搭桥术联合应用于经皮冠状动脉介入治疗的疗效)评分预测非保护左主干冠状动脉血运重建术后结局的验证。
JACC Cardiovasc Interv. 2010 Jun;3(6):612-23. doi: 10.1016/j.jcin.2010.04.004.
5
Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.对比 NERS(新风险分层)评分和 SYNTAX(经皮冠状动脉介入治疗与心脏手术联合治疗)评分在非保护左主干支架置入术预后预测中的价值。
JACC Cardiovasc Interv. 2010 Jun;3(6):632-41. doi: 10.1016/j.jcin.2010.04.006.
6
3-Dimensional bifurcation angle analysis in patients with left main disease: a substudy of the SYNTAX trial (SYNergy Between Percutaneous Coronary Intervention with TAXus and Cardiac Surgery).左主干病变患者的三维分叉角度分析:SYNTAX 试验(经皮冠状动脉介入治疗与心脏手术的协同作用)的一个亚研究。
JACC Cardiovasc Interv. 2010 Jan;3(1):41-8. doi: 10.1016/j.jcin.2009.10.019.
7
Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft.SYNTAX评分在选择接受冠状动脉旁路移植术治疗的左主干冠状动脉疾病患者中的应用价值。
JACC Cardiovasc Interv. 2009 Aug;2(8):731-8. doi: 10.1016/j.jcin.2009.06.003.
8
Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.药物洗脱支架经皮冠状动脉介入治疗与旁路手术治疗 3 支血管病变或左主干病变患者的成本效益:紫杉醇药物洗脱支架与心脏手术(SYNTAX)试验的最终结果。
Circulation. 2014 Sep 30;130(14):1146-57. doi: 10.1161/CIRCULATIONAHA.114.009985. Epub 2014 Aug 1.
9
The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial.不完全血运重建对临床结局的负面影响及其与完全闭塞的关系:SYNTAX(紫杉醇药物涂层支架与心脏搭桥术的SYNERGY)试验。
J Am Coll Cardiol. 2013 Jan 22;61(3):282-94. doi: 10.1016/j.jacc.2012.10.017. Epub 2012 Dec 19.
10
Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial.在 Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery(SYNTAX)试验中,经皮冠状动脉介入治疗使用紫杉醇洗脱支架或冠状动脉旁路移植术治疗新发左主干疾病患者的结局。
Circulation. 2010 Jun 22;121(24):2645-53. doi: 10.1161/CIRCULATIONAHA.109.899211. Epub 2010 Jun 7.

引用本文的文献

1
Surgical and percutaneous revascularization outcomes based on SYNTAX I, II, and residual scores: a long-term follow-up study.基于 SYNTAX I、II 和残余评分的手术和经皮血运重建结果:一项长期随访研究。
J Cardiothorac Surg. 2021 Sep 3;16(1):248. doi: 10.1186/s13019-021-01616-6.
2
Clinical Implications of Early Exercise Treadmill Testing after Percutaneous Coronary Intervention in the Drug-eluting Stent Era.药物洗脱支架时代经皮冠状动脉介入治疗后早期运动平板试验的临床意义。
J Korean Med Sci. 2020 Jul 13;35(27):e229. doi: 10.3346/jkms.2020.35.e229.
3
Clinical SYNTAX Score - a good predictor for renal artery stenosis in acute myocardial infarction patients: analysis from the REN-ACS trial.
临床SYNTAX评分——急性心肌梗死患者肾动脉狭窄的良好预测指标:来自REN-ACS试验的分析
Arch Med Sci. 2017 Jun;13(4):837-844. doi: 10.5114/aoms.2016.60374. Epub 2016 Jun 6.
4
Pentraxin 3 Is Highly Specific for Predicting Anatomical Complexity of Coronary Artery Stenosis as Determined by the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery Score.Pentraxin 3 对经皮冠状动脉介入治疗与心脏手术评分联合预测冠状动脉狭窄解剖复杂性具有高度特异性。
Korean Circ J. 2014 Jul;44(4):220-6. doi: 10.4070/kcj.2014.44.4.220. Epub 2014 Jul 25.